Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two ...

By Anusha Shah and Amina Niasse Feb 7 (Reuters) - Online telehealth company Hims & Hers on Saturday reversed course on its ...

Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal ...

Telehealth company Hims & Hers cancels $49 monthly weight loss drug launch following FDA warnings about unapproved ...

Lilly plans to advertise Zepbound during NBC's pre-game show as well as during the game on its Peacock streaming service.

Hims & Hers Health Inc. announced it will stop selling a copycat version of Novo Nordisk's Wegovy weight-loss pill two days ...

Hims & Hers announced they are scrapping plans to sell a compounded version of the weight loss drug Wegovy after federal regulators vowed to take action against the telehealth provider. “Since ...

Hims Hers Health announced on Saturday that it will stop offering access to its compounded semaglutide pill following a ...

Hims & Hers said it would stop selling its new compounded semaglutide pill after "constructive conversations with ...

On Thursday, Hims & Hers Health Inc. (NYSE:HIMS) announced Thursday an expansion of its weight loss specialty by enabling ...

Following escalating legal threats from federal regulators regarding plans to sell an unapproved form of Novo Nordisk’s Wegovy pill, Hims said it “decided to stop offering access” to the treatment.

And the main attraction will have to compete with the commercials: George Clooney, Sabrina Carpenter, Matthew McConaughey and ...